Clinical trial Recruiting at 1 site Observational Ages 5 to 90

Photon-counting CT to check intracranial stents

Official title: Evaluation of Ultra-high Resolution Photon-counting CT Angiography for Intracranial Stent Assessment: A Prospective Diagnostic Study With Digital Subtraction Angiography as Reference Standard

Run by Chinese PLA General Hospital · NCT07769814 · Data updated 2026-11-12

This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.

Quick facts

Study typeObservational
Ages5 Years to 90 Years
SexAll
Enrollment200 (estimated)
SponsorChinese PLA General Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 7, 2026
Main results expectedJanuary 7, 2029
Study endsJanuary 7, 2029
Registry record updatedAugust 18, 2026
Trial IDNCT07769814 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with a previously implanted intracranial arterial stent who are undergoing follow-up CTA and have imaging data available for analysis.

Probably not a fit

Patients without detectable stent visualization artifacts or without restenosis may not experience additional benefit from this imaging approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study evaluates the use of photon-counting detector CT angiography to assess intracranial stents in adults with prior intracranial arterial stents. By leveraging higher spatial resolution and reduced artifacts, the study aims to determine the technology's ability to visualize stent lumen and identify restenosis compared with standard imaging parameters. Participants are adults undergoing routine CTA follow-up, with imaging data collected for analysis. The investigation addresses whether this noninvasive modality can provide accurate, noninvasive surveillance and potentially reduce the need for invasive DSA in some cases.

Why it matters

Potential benefit: If successful, photon-counting CT could provide clearer, noninvasive monitoring of intracranial stents and accurate detection of restenosis.

How similar studies have gone: Previous evidence suggests newer CT technologies can reduce metal artifacts and improve stent visualization, but results for intracranial applications remain exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years;
2. Patients with previously implanted intracranial arterial stents;
3. Undergoing follow-up CTA examination;
4. Available imaging data for analysis.

Exclusion Criteria:

1. Severe motion artifacts;
2. Poor contrast enhancement;
3. Incomplete clinical or imaging data.

Where it's running

  • Chinese PLA General Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.